Role of factor XIII Val 34 Leu polymorphism in patients with migraine

Cephalalgia

Volumn 21, Issue 8, 2001, Pages 837-841

  Iniesta, J A ^a   Corral, J ^a   Gonzalez Conejero R ^a   Di'az Ortuno A ^a   Marti'nez Navarro, M L ^a   Vicente, V ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

Factor XIII; Migraine; Polymorphism; Risk factor

Indexed keywords

BLOOD CLOTTING FACTOR 13; OLIGONUCLEOTIDE;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; EPILEPTIC AURA; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; POLYMERASE CHAIN REACTION; PREVALENCE; SPAIN;

ADULT; AGED; CEREBROVASCULAR DISORDERS; FACTOR XIII; FEMALE; GENOTYPE; HUMANS; LEUCINE; MALE; MIDDLE AGED; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; VALINE;

EID: 0035740783     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0333-1024.2001.00273.x     Document Type: Article

References (25)

1. Human factor XIII fibrin-stabilizing factor
2. Gene defects in congenital factor XIII deficiency
3. Genotype/phenotype correlations for coagulation factor XIII. Specific normal polymorphisms are associated with high or low factor XIII specific activity
4. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
5. Association of a common polymorphism in the factor XIII gene with myocardial infarction
6. Association of a common polymorphism in the factor XIII gene with venous thrombosis
7. Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis
8. Epidemiology of stroke
9. Association between migraine and stroke in a large-scale epidemiological study in the United States
10. Migraine and migrainous stroke: Risk factors and prognosis
11. Arg506Gln Factor V mutation (Factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction
12. Migraine and prothrombotic genetic risk factors
13. Special report: Classification of cerebrovascular diseases III
14. Pravastatin therapy and the risk of stroke
15. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
16. Characterization of a cDNA coding for human factor XIIIa
17. Detection of factor V Leiden from a droop of blood by PCR-SSCP
18. The Val34Leu polymorphism in the A subunit coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity
19. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure
20. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A
21. Val34Leu polymorphism of plasma FXIII. Biochemistry and epidemiology in familial thrombophilia
22. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity
23. Val34Leu. A novel association with primary intracerebral hemorrhage
24. Factor XIII Val34Leu polymorphism in primary intracerebral haemorrhage
25. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism